https://www.almirall.com 2026-05-11T15:17:07+00:00 weekly 1 https://www.almirall.com/company 2026-04-24T11:16:38+00:00 weekly 1 https://www.almirall.com/company/about-us 2026-04-30T13:23:33+00:00 weekly 1 https://www.almirall.com/company/suppliers 2026-04-30T09:51:06+00:00 weekly 1 https://www.almirall.com/company/purpose 2026-04-28T10:27:15+00:00 weekly 1 https://www.almirall.com/patients 2026-04-24T10:41:59+00:00 weekly 1 https://www.almirall.com/company/locations 2026-04-27T14:43:38+00:00 weekly 1 https://www.almirall.com/company/sustainability/people 2026-05-11T18:34:08+00:00 weekly 1 https://www.almirall.com/company/sustainability/principles 2026-04-28T07:17:50+00:00 weekly 1 https://www.almirall.com/patients/psychological-well-being 2026-04-29T10:18:05+00:00 weekly 1 https://www.almirall.com/patients/commitment/campaigns 2026-04-28T11:39:22+00:00 weekly 1 https://www.almirall.com/company/sustainability/planet 2026-05-11T16:56:53+00:00 weekly 1 https://www.almirall.com/company/sustainability 2026-05-12T11:23:12+00:00 weekly 1 https://www.almirall.com/company/sustainability/patients 2026-04-27T12:47:57+00:00 weekly 1 https://www.almirall.com/company/sustainability/partners 2026-05-11T15:30:05+00:00 weekly 1 https://www.almirall.com/patients/stories 2026-04-28T07:30:08+00:00 weekly 1 https://www.almirall.com/patients/commitment/campaigns/sanctuary-salon 2026-05-12T09:17:21+00:00 weekly 1 https://www.almirall.com/investors 2026-05-11T21:52:39+00:00 weekly 1 https://www.almirall.com/investors/CNMV-communications 2026-05-11T11:17:01+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance 2026-04-27T10:44:20+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/annual-meeting 2026-05-11T20:32:00+00:00 weekly 1 https://www.almirall.com/innovation/clinical-trials 2026-05-11T12:38:21+00:00 weekly 1 https://www.almirall.com/innovation/rd-collaboration 2026-05-08T07:31:54+00:00 weekly 1 https://www.almirall.com/innovation/partnering 2026-05-11T09:01:59+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/agreements 2026-04-27T10:56:39+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/board-directors 2026-05-11T08:38:12+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/board-comissions 2026-05-11T14:19:30+00:00 weekly 1 https://www.almirall.com/dermatology 2026-04-24T10:44:16+00:00 weekly 1 https://www.almirall.com/investors/reports/annual 2026-05-11T16:07:25+00:00 weekly 1 https://www.almirall.com/investors/reports/annual/2021 2026-04-29T10:40:40+00:00 weekly 1 https://www.almirall.com/innovation 2026-05-11T08:54:52+00:00 weekly 1 https://www.almirall.com/investors/stock-information 2026-04-27T10:00:34+00:00 weekly 1 https://www.almirall.com/investors/stock-information/share-performance 2026-04-27T10:06:24+00:00 weekly 1 https://www.almirall.com/investors/stock-information/share-capital 2026-04-27T10:13:09+00:00 weekly 1 https://www.almirall.com/investors/stock-information/analyst-coverage 2026-04-27T10:20:42+00:00 weekly 1 https://www.almirall.com/investors/stock-information/actions-financing 2026-05-12T08:29:48+00:00 weekly 1 https://www.almirall.com/investors/financial-data/results-accounts 2026-05-11T11:04:30+00:00 weekly 1 https://www.almirall.com/investors/financial-data/public-information 2026-04-29T10:17:32+00:00 weekly 1 https://www.almirall.com/investors/financial-data/information-materials 2026-04-29T10:17:24+00:00 weekly 1 https://www.almirall.com/innovation/pipeline 2026-04-27T14:48:38+00:00 weekly 1 https://www.almirall.com/investors/leadership 2026-04-27T13:18:50+00:00 weekly 1 https://www.almirall.com/investors/reports 2026-04-27T13:50:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom 2026-05-08T07:06:36+00:00 weekly 1 https://www.almirall.com/patients/commitment 2026-05-08T14:16:24+00:00 weekly 1 https://www.almirall.com/investors/compliance 2026-04-27T11:07:19+00:00 weekly 1 https://www.almirall.com/company/integrity 2026-03-31T15:54:52+00:00 weekly 1 https://www.almirall.com/company/faq 2026-04-28T07:31:39+00:00 weekly 1 https://www.almirall.com/company/faq/products 2026-04-28T08:02:20+00:00 weekly 1 https://www.almirall.com/company/faq/pathology 2026-04-28T07:50:48+00:00 weekly 1 https://www.almirall.com/company/faq/therapeutic-areas 2026-04-28T07:51:14+00:00 weekly 1 https://www.almirall.com/investors/leadership/management-board 2026-05-11T08:44:49+00:00 weekly 1 https://www.almirall.com/company/history 2026-04-30T09:21:17+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/governance-director 2026-04-16T09:32:32+00:00 weekly 1 https://www.almirall.com/contact/report-side-effect 2026-04-28T09:25:03+00:00 weekly 1 https://www.almirall.com/investors/corporate-governance/corporate-policies 2026-04-28T11:42:08+00:00 weekly 1 https://www.almirall.com/news-media/contact 2026-04-30T10:54:59+00:00 weekly 1 https://www.almirall.com/news-media/event-calendar 2026-04-30T10:54:18+00:00 weekly 1 https://www.almirall.com/news-media 2026-04-30T10:49:15+00:00 weekly 1 https://www.almirall.com/contact/media 2026-04-14T10:49:13+00:00 weekly 1 https://www.almirall.com/contact/investors 2026-04-28T07:51:54+00:00 weekly 1 https://www.almirall.com/contact/research-development-activities 2026-04-14T10:49:21+00:00 weekly 1 https://www.almirall.com/contact/people-culture 2026-04-28T07:51:18+00:00 weekly 1 https://www.almirall.com/contact/partners 2026-04-28T07:50:41+00:00 weekly 1 https://www.almirall.com/contact/medical-information 2026-04-28T07:49:46+00:00 weekly 1 https://www.almirall.com/contact/help-us-to-improve 2026-04-14T10:49:36+00:00 weekly 1 https://www.almirall.com/news-media/media-resources 2026-05-11T09:29:56+00:00 weekly 1 https://www.almirall.com/patients/commitment/campaigns/sanctuary-salon/patients 2026-05-12T09:21:16+00:00 weekly 1 https://www.almirall.com/terms-conditions 2026-04-20T14:59:06+00:00 weekly 1 https://www.almirall.com/company/sustainability/transparency 2026-05-11T07:06:13+00:00 weekly 1 https://www.almirall.com/global-privacy-policy 2026-04-20T14:47:31+00:00 weekly 1 https://www.almirall.com/privacy-policy 2026-04-20T13:46:56+00:00 weekly 1 https://www.almirall.com/privacy-policy-hcp 2026-04-20T14:22:36+00:00 weekly 1 https://www.almirall.com/accessibility-policy 2026-04-29T08:41:51+00:00 weekly 1 https://www.almirall.com/cookies 2026-04-20T14:36:36+00:00 weekly 1 https://www.almirall.com/terms-of-use 2026-04-20T14:41:40+00:00 weekly 1 https://www.almirall.com/drug-safety 2026-04-20T14:45:48+00:00 weekly 1 https://www.almirall.com/company/sustainability/other-relevant-documentation 2026-05-11T10:24:51+00:00 weekly 1 https://www.almirall.com/contact 2026-04-30T10:50:14+00:00 weekly 1 https://www.almirall.com/career-privacy-notice 2026-04-24T11:58:33+00:00 weekly 1 https://www.almirall.com/healthcare-professional/products 2026-05-08T14:36:49+00:00 weekly 1 https://www.almirall.com/healthcare-professional 2026-04-29T10:11:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-recognized-top-employer-spain-and-germany 2026-04-15T08:53:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-meets-2025-guidance-delivering-124-net-sales-growth-and-continued 2026-04-27T09:31:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/women-advancing-science 2026-04-09T09:46:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/advancing-medical-dermatology-innovation-through-partnerships-china 2026-05-11T11:29:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/uncommon-nature-thinking-differently-shape-future-medical-dermatology 2026-04-16T13:29:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/skin-academy-advancing-scientific-exchange-and-holistic-care-medical 2026-04-09T09:46:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further 2026-04-22T14:31:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-approval-seysarar-china-treatment-moderate-severe-acne 2026-04-15T08:46:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-lumine-phase-iii-clinical-study-assessing-efficacy 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-presents-rd-pipeline-advances-supported-sustained-growth-and 2026-04-15T08:59:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-immunoskin-gathers-leading-experts-advance-science-and-treatment 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net 2026-04-15T11:42:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-presents-long-term-results-first-real-world-dermatology-study-using 2026-04-15T08:46:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/eadv-2025-almirall-advances-skin-science-and-leads-innovation-holistic-patient 2026-04-15T08:46:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-absci-expand-ai-drug-creation-collaboration-adding-second 2026-04-15T08:46:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth 2026-04-15T11:44:35+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-shows-efficacy-biologics-real-world-evidence-and-new-patient-centric 2026-04-15T08:46:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-leads-paradigm-shift-holistic-patient-care-dermatology-applying-who-5 2026-04-15T08:46:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its 2026-04-15T11:44:49+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-biofrontera-launch-hats-challenge-raise-awareness-and-support 2026-04-15T08:46:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-16th-skin-academy-brings-together-leading-experts-advance-skin 2026-04-15T08:46:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-cfo-transition-plan-and-appoints-jon-u-garay-alonso-cfo 2026-04-15T08:46:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further 2026-04-15T11:45:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-jpmorgan-conference-entering-new-era-sustained-growth 2026-04-15T08:46:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-almirall-innovation-hub-hive-creating-novel-collaborative 2026-04-15T08:46:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024 2026-04-15T11:45:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-campaign-me-my-inner-circle-acknowledge-vital-role-friends 2026-04-15T09:00:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-2024-immunoskin-conference-hosts-leading-experts-inflammatory-skin 2026-04-15T08:46:17+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-completion-decentralized-regulatory-approval-procedure 2026-04-15T08:46:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/new-data-show-almiralls-ebglyssr-lebrikizumab-provided-sustained-disease 2026-04-15T08:46:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/33rd-congress-european-academy-dermatology-and-venereology-eadv 2026-04-15T08:46:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/14th-september-world-atopic-eczema-day 2026-04-15T08:46:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-2024-results 2026-04-15T08:46:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/nice-recommends-ebglyss-lebrikizumab-use-moderate-severe-atopic-dermatitis-nhs 2026-04-15T08:46:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-act4impact-its-updated-sustainability-strategy-setting 2026-04-15T08:46:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-ilumetrir-tildrakizumab-demonstrates-high-rates-skin-clearance-and 2026-04-15T08:46:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/fda-approves-almiralls-klisyrir-tirbanibulin-treatment-actinic-keratosis 2026-04-15T08:46:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/ebglyssr-lebrikizumab-ranked-number-one-interleukin-inhibitors-severe-atopic 2026-04-15T08:46:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/may-24th-actinic-keratosis-ak-global-day 2026-04-15T08:46:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales 2026-04-15T11:45:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013 2026-04-15T10:32:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-licenses-anti-il-21-monoclonal-antibody-novo-nordisk-develop-it-first 2026-04-15T08:46:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-rating-cdp-its-contributions-fight-against-climate-change 2026-04-15T08:46:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-partnership-centre-genomic-regulation-crg-identify 2026-04-15T08:46:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-microsoft-announce-partnership-digital-transformation-enable 2026-04-15T08:46:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-initiates-first-phase-i-clinical-study-alm223-interleukin-2-mutant 2026-04-15T08:46:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-participate-42nd-annual-jp-morgan-healthcare-conference 2026-04-15T08:46:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-etherna-enter-multi-target-alliance-develop-mrna-based-therapies 2026-04-15T08:46:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-barcelona-supercomputing-center-bsc-and-nostrum-biodiscovery 2026-04-15T08:46:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-european-commission-approval-ebglyssr-lebrikizumab-moderate 2026-04-15T08:46:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-absci-announce-ai-drug-discovery-partnership-rapidly-develop-novel 2026-04-15T08:46:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology 2026-04-15T11:47:05+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/psoriasis-was-found-impact-wellbeing-similar-level-breast-cancer 2026-04-15T08:46:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-opens-new-call-proposals-better-understand-key-pathological-mechanisms 2026-04-15T08:46:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-nearly-80-patients-moderate-severe-atopic-dermatitis-maintained-clear 2026-04-15T08:46:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-lebrikizumab-improves-signs-and-symptoms-moderate-severe-atopic 2026-04-15T08:46:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/epimab-biotherapeutics-and-almirall-announce-bispecific-antibody-license 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-ilumetrir-tildrakizumab-significantly-improves-wellbeing-patients-and 2026-04-15T08:46:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/centrient-pharmaceuticals-joins-almiralls-growing-innovation-hub-barcelona 2026-04-15T08:46:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/ebglyssr-lebrikizumab-receives-positive-chmp-opinion-moderate-severe-atopic 2026-04-15T08:46:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/moving-ahead-almirall-message-raise-awareness-about-atopic-eczema 2026-04-15T08:46:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european 2026-04-15T11:46:45+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/science-based-targets-initiative-sbti-validates-almiralls-2030-emission 2026-04-15T08:46:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-ilumetrir-tildrakizumab-significantly-improved-wellbeing-patients 2026-04-15T08:46:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-pricing-and-closing-its-eu200mm-non-pre-emptive-share 2026-04-15T08:46:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-launch-eu200mm-non-pre-emptive-share-capital-increase 2026-04-15T08:46:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-nina-first-series-highlight-major-impact-psoriasis-patients 2026-04-15T08:46:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-centre-genomic-regulation-crg-collaborate-develop-and-characterize 2026-04-15T08:46:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/85-people-unaware-actinic-keratosis-most-common-pre-cancerous-skin-condition 2026-04-15T08:46:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european 2026-04-15T11:46:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-73-atopic-dermatitis-patients-taking-lebrikizumab-had-improved-or 2026-04-15T08:46:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-first-assess-wellbeing-dermatology-clinical-study 2026-04-15T08:46:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-new-england-journal-medicine-nejm-and-british-journal-dermatology-bjd 2026-04-15T08:46:37+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-opens-doors-its-rd-centre-biotech-zeclinics 2026-04-15T08:59:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66 2026-04-15T11:46:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-participate-41st-annual-jp-morgan-healthcare-conference 2026-04-15T08:46:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-mercedes-diz-vp-corporate-strategy 2026-04-15T08:46:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-2022-results 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration 2026-04-15T08:46:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022 2026-04-15T12:14:57+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-15T08:46:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-new-research-collaboration-university-dundee-develop 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-collaboration-university-michigan-gain-understanding-disease 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions 2026-04-15T08:46:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-2021-results 2026-04-15T08:46:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-roadmap-more-sustainable-future 2026-04-15T08:46:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/experts-highlight-need-focus-psoriasis-patients-wellbeing-clinical-practice 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-klisyrirvtirbanibulin-treatment-actinic-keratosis-europe 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-15T08:46:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin 2026-04-15T10:48:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-2020-full-year-results 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-mc2-therapeutics-enter-license-collaboration-and-commercialization 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-new-england-journal-medicine-publication-phase-iii-data 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-happify-health-enter-strategic-partnership-develop-evidence 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-collaborations-university-south-australia-and-fundacio 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-university-dundee-announce-multi-target-research-collaboration 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-enters-ibex-35 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-e-ms-experts-summit-season-2020 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/solid-q1-2020-performance 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announcement 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application-0 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-2019-results-strong-operational-performance-excellent 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-15T08:47:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-15T12:17:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/volker-koscielny-new-chief-medical-officer-and-new-member-management-board 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-accelerator-digital-garden-drive-digital-innovation 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-llc-announces-publication-long-term-safety-data-use-seysarar 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-9m-2019-business-results-continued-good-business-momentum-driven 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/duaklirr-will-be-available-united-states-21st-october 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-revalidates-its-excellence-occupational-health-and-safety-environment 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-q1-2019-strong-operating-performance 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-recognized-distinguished-corporate-leader-american-skin-association 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase 2026-04-15T10:50:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-nuevolution-partnership-achieves-first-collaboration-milestone 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-2018-results 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-dermira-enter-option-and-license-agreement-european-rights 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-0 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-refinance-us-medical-dermatology-acquisition 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-9m-2018-business-results-strong-business-momentum 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-seeks-new-compounds-improve-skin-health 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-q1-2018-encouraging-financial-results 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-2017-results 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalift-tm 2026-04-15T10:50:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q3-results-2017 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-peter-guenter-new-ceo 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-guidance-update-2017 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/international-experts-elaborate-consensus-effects-present-and-potential-medical 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/data-tildrakizumab-clinical-development-program-presented-2017-american-academy 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-full-year-2016-results-strong-dermatology-results-and-promising 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-restructuring-plan-spain 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reaches-agreement-acquire-100-poli-group 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-september-ytd-results-2015-operational-business-outperformance-driven 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-full-year-2014-results-line-guidance 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q1-results-2014-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/forest-laboratories-and-almirall-provide-update-fixed-dose-combination 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights 2026-04-15T12:22:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and 2026-04-15T12:23:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-accident-rate-spain-2013-down-20 2026-04-15T08:48:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-15T08:48:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty 2026-04-15T12:23:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-reorganization-program-affecting-group-europe 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/international-pharmaceutical-company-almirall-expands-global-footprint-new 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-15T08:48:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system 2026-04-15T08:48:59+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments 2026-04-15T12:24:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are 2026-04-15T12:25:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-begins-transformation 2026-04-15T08:49:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-maintains-its-shareholder-return-thanks-its-rd-and 2026-04-15T08:59:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii 2026-04-15T12:26:17+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-presents-latest-news-respiratory-diseases 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-celebrates-10-years-italy 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-financial-calendar-2013 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm 2026-04-15T12:27:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome 2026-04-15T12:28:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-15T08:49:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/3rd-quarter-results 2026-04-15T08:49:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent 2026-04-15T12:29:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-15T11:57:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-incorporates-gerhard-mayr-board-directors 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-licenses-aclidinium-invida-australia-and 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/linaclotide-receives-positive-chmp-opinion-treatment-ibs-c 2026-04-15T08:49:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-15T10:58:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-obtains-rights-linaclotide-mexico 2026-04-15T08:49:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-opens-new-affiliate-canada 2026-04-15T08:49:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose 2026-04-15T11:51:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-h1-strong-newsflow-and-guidance-reiterated 2026-04-15T08:49:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance 2026-04-15T11:56:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm 2026-04-15T12:30:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar-investigacion-y 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-15T12:31:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-aclidinium-recommended-approval-europe-treat-copd 2026-04-15T08:49:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-aslan-sign-global-agreement-novel-treatment-rheumatoid-arthritis 2026-04-15T08:49:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-starts-third-phase-iii-clinical-trial-cancer-pain 2026-04-15T08:49:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/new-strategic-direction-almiralls-od-laba-following-successful-phase-iia 2026-04-15T08:49:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-present-aclidinium-bromide-clinical-data-american-thoracic 2026-04-15T08:49:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-grows-internationally 2026-04-15T08:49:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-mutual-recognition-procedure-closes-recommendation-approval-ten 2026-04-15T08:49:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-annual-general-meeting-approves-018-euro-pay-out-share-scrip-dividend 2026-04-15T08:49:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-has-extended-review-period 2026-04-15T08:49:17+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-menarini-sign-licence-agreement-and-commercial-alliance-aclidinium 2026-04-15T08:49:17+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aclidinium-clinical-data-published-european-respiratory-journal-confirms 2026-04-15T12:31:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/el-tratamiento-personalizado-de-la-epoc-principal-reto-para-los-especialistas 2026-04-15T08:49:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-extends-sativexr-marketing-rights-mexico 2026-04-15T08:49:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two 2026-04-15T12:32:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-results-2011-line-positive-newsflow-start-2012 2026-04-15T08:49:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-fda-advisory-committees-recommendation 2026-04-15T08:49:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/la-vi-reunion-vam-presenta-las-nuevas-evidencias-en-el-tratamiento-de-las 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-licenses-aclidinium-daewoong-korea 2026-04-15T08:49:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/desciende-el-tabaquismo-pasivo-gracias-la-ley-antitabaco-y-se-mantiene-el 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/bayer-and-almirall-co-promote-anticoagulant-rivaroxaban-spain 2026-04-15T08:49:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-15T12:32:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-celebrates-10-years-mexico 2026-04-15T08:49:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-galapagos-enter-research-alliance 2026-04-15T08:49:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-colabora-con-la-fundacion-vicente-ferrer-en-un-proyecto-de 2026-04-15T08:49:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-solarazer-spain-treatment-actinic-keratosis 2026-04-15T08:49:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-15T12:33:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-biofocus-announce-collaboration-find-new-hit-compounds-against-key 2026-04-15T08:49:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-colabora-con-la-sed-en-el-dia-mundial-de-la-diabetes-only-available 2026-04-15T08:49:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/mas-de-la-mitad-de-los-diabeticos-tipo-2-no-tiene-un-control-adecuado-de-la 2026-04-15T08:49:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/q3-results-almirall-prepares-future-growth 2026-04-15T08:49:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/8-de-cada-10-espanoles-no-sabe-que-es-la-epoc 2026-04-15T08:49:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/full-phase-iii-data-highlight-efficacy-and-tolerability-sativexr-therapy 2026-04-15T08:49:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/linaclotide-provides-long-term-relief-symptoms-irritable-bowel-syndrome 2026-04-15T08:49:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-lundbeck-announce-co-promotion-agreement-escitalopram-italy 2026-04-15T08:49:26+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-spanish-pharmacological-society-recognise-research-diabetes 2026-04-15T08:49:27+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-roflumilast-spain 2026-04-24T12:32:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-regulatory-filing-linaclotide-treatment-irritable-bowel 2026-04-15T08:49:27+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key 2026-04-15T11:40:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis 2026-04-15T11:55:17+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/copd-patients-experienced-benefits-first-dose-when-treated-aclidinium-shown 2026-04-15T08:49:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-enters-integrated-discovery-agreement-proteros 2026-04-15T08:49:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-15T11:37:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-h1-financial-results 2026-04-15T08:49:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aclidinium-bromide-submitted-registration-europe 2026-04-15T08:49:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-strengthens-its-german-business-two-new-products-sativexr-and 2026-04-15T08:49:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-15T11:36:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-announce-regulatory-submission-aclidinium-bromide-treatment 2026-04-15T08:49:32+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir 2026-04-15T11:53:42+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-15T11:54:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/la-sepd-en-colaboracion-con-almirall-presenta-el-libro-el-paciente-con-sintomas 2026-04-15T08:49:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-approved-denmark-treatment-spasticity-due-multiple-sclerosis-ms 2026-04-15T08:49:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/actikerallr-launched-uk-treatment-actinic-keratosis-including-grade-i-and-ii 2026-04-15T08:49:33+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-15T11:37:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-strengthens-their-ongoing-commitment-patients-multiple-sclerosis 2026-04-15T08:49:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-approved-germany-treatment-spasticity-due-multiple-sclerosis 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-q1-financial-results-line-attain-yearly-guidance 2026-04-15T08:49:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-15T11:34:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-present-data-phase-iii-studies-aclidinium-bromide-chronic 2026-04-15T08:49:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/regulators-confirm-actikerallr-treatment-actinic-keratoses-including-grade-i 2026-04-15T08:49:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-15T11:35:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/el-tabaquismo-es-la-enfermedad-respiratoria-mas-frecuente 2026-04-15T08:49:37+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-strengthens-its-respiratory-franchise-new-generation-chronic 2026-04-15T11:36:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de 2026-04-15T11:36:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism 2026-04-15T11:32:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-15T11:36:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-mutual-recognition-procedure-closes-recommendation-approval-all-six 2026-04-15T08:49:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/lanzamiento-balneum-intensive-espana 2026-04-15T08:49:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-15T12:35:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-launched-spain-treat-spasticity 2026-04-15T08:49:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-2010-financial-results-line-guidance 2026-04-15T08:49:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-15T11:33:09+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-15T11:33:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion 2026-04-15T11:34:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-15T08:49:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-15T11:31:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por 2026-04-15T11:30:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/bertil-lindmark-new-executive-director-rd-almirall 2026-04-21T10:00:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium 2026-04-15T11:29:54+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-15T08:49:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/q3-line-guidance-rd-momentum-continues 2026-04-15T08:59:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial 2026-04-15T08:49:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii 2026-04-15T08:50:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su 2026-04-15T11:32:29+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy 2026-04-15T08:50:00+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews 2026-04-15T11:12:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign 2026-04-15T11:12:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare 2026-04-15T11:17:45+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and 2026-04-15T11:10:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-15T08:50:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide 2026-04-15T11:10:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-15T11:28:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/first-half-2010-line-guidance-strong-rd-catalysts-expected-second-half 2026-04-15T08:58:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/sativexr-receives-regulatory-authorisation-spain 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new 2026-04-15T11:28:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004 2026-04-15T11:09:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del 2026-04-15T11:09:06+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-15T08:50:05+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-international-agreement-basilea-commercialize-toctinor 2026-04-15T12:39:04+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de 2026-04-15T12:39:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/regulators-uk-and-spain-confirm-sativexr-approvable 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5 2026-04-15T08:50:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-first-quarter-2010-track 2026-04-15T08:50:08+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/20-years-antihistamine-ebastelr-ebastine 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick 2026-04-15T08:50:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-15T11:08:37+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika 2026-04-15T08:50:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/emeachmp-adopts-positive-opinion-silodosin 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd 2026-04-15T11:24:03+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-filing-sativexr-regulatory-submission 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-15T08:50:21+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin 2026-04-15T08:50:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel 2026-04-15T08:50:22+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-respiratory-pipeline-update-aclidinium-bromide-and-las100977-once 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london 2026-04-15T08:50:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/steve-webber-new-senior-discovery-director-almirall 2026-04-15T08:50:23+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new 2026-04-15T08:50:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-15T08:50:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/encouraging-results-support-further-development-almiralls 2026-04-15T10:32:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/between-15-and-20-population-will-suffer-depression-some-time-during-their 2026-04-15T11:21:30+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-moving-forward-development-aclidinium-bromide 2026-04-15T11:20:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories 2026-04-15T10:32:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-spanish-society-pharmacology-confer-pharmacology-award-2008 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/marketing-sales-team-almirall-germany-has-received-golden-tablet-award-best 2026-04-15T09:00:25+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/phase-iii-clinical-studies-aclidinium-bromide-show-statistical-significance-vs 2026-04-15T08:50:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/clarification-regarding-news-almirall-receiving-offer-acquiring-package 2026-04-15T08:50:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-around-547-million-euros-first-half-year 2026-04-15T08:50:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-15T08:50:41+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-proteros-biostructures-announce-successful-achievement-key 2026-04-15T08:50:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/laboratorios-almirall-sa-and-forest-laboratories-inc-complete-phase-iii-studies 2026-04-15T08:50:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/doctors-and-pharmacists-pool-knowledge-tackle-digestive-diseases 2026-04-15T08:50:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/philippe-bouissou-new-senior-development-director-almirall 2026-04-15T08:50:43+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-clinical-studies 2026-04-15T08:50:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-obtains-total-revenues-269-million-euros-first-quarter-year 2026-04-15T08:50:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-awards-dividend-40-its-shareholders 2026-04-15T08:50:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reinforces-its-european-expansion-opening-new-affiliates-poland-and 2026-04-15T08:50:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-promising-results-new-compound-asthma-and-copd 2026-04-15T08:50:46+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/israel-garcia-and-ma-eugenia-vellve-new-almirall-general-managers-mexico-and 2026-04-15T08:50:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reports-total-revenues-917-million-euros-2007 2026-04-15T08:50:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/carlos-gallardo-general-manager-almirall-united-kingdom-and-ireland 2026-04-15T08:50:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reinforces-its-presence-europe-opening-new-affiliate-united-kingdom 2026-04-15T08:50:49+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-acquisition-portfolio-8-products-shire-plc 2026-04-15T08:50:49+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-contributes-almost-2-million-euros-renew-collaboration-agreement 2026-04-15T08:50:49+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-increases-its-net-sales-38 2026-04-15T08:50:49+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/christophe-vandeputte-and-dominique-humblet-new-almirall-general-managers 2026-04-15T08:50:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/anselm-divi-new-almirall-corporate-director-human-resources 2026-04-15T08:50:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-acquires-portfolio-eight-products-shire-plc-us213-million-eu151 2026-04-15T08:50:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/klaus-melchers-new-senior-discovery-director-almirall 2026-04-15T08:50:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-spanish-pharmacology-society-confer-pharmacology-award-2007 2026-04-15T08:50:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aclidinium-bromide-demonstrates-rapid-and-long-acting-bronchodilatory-effect 2026-04-15T08:50:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-process-acquisition-hermal-after-clearance-german-regulatory 2026-04-15T08:50:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-closes-its-acquisition-hermal-after-clearance-german-regulatory 2026-04-15T08:50:52+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-half-year-results-2007-almirall-reports-net-sales-4129-million-euros 2026-04-15T08:50:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reports-net-sales-4129-million-euros 2026-04-15T08:50:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/gonzalo-de-miquel-new-global-medical-director-almirall-rd-area 2026-04-15T09:13:45+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-again-receives-iso-140012004-environmental-management-certificate 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-acquires-hermal-european-prescription-dermatology-business-reckitt 2026-04-15T08:50:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-priced-14-euros-share-its-first-day-listed-company 2026-04-15T08:50:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-shares-close-first-day-trading-rising-714-over-offer-price 2026-04-15T08:50:55+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/jordi-molina-alsina-investor-relations-manager-almirall 2026-04-15T08:50:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/CNMV-spanish-stock-exchange-commission-registers-prospectus-public-offering 2026-04-15T08:50:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-will-reserve-shares-its-stock-market-listing-company-employees 2026-04-15T08:50:56+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-15T11:03:47+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-certifies-its-occupational-risk-prevention-management-system 2026-04-15T08:50:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-selects-morgan-stanley-and-santander-next-phase-stock-market-listing 2026-04-15T08:50:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-its-intention-list-its-shares-spanish-stock-market 2026-04-15T08:50:58+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign 2026-04-15T11:04:51+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-15T11:05:11+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/stress-and-anxiety-are-among-main-causes-acidity-spain 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-confers-2006-pharmacology-award-during-spanish-pharmacology-society 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-extends-its-collaboration-sareum 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/strategic-partnership-almirall-meda 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/his-majesty-king-spain-inaugurates-almiralls-new-research-and-development 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-new-research-and-development-centre-reference-point-biomedical 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-expands-12-international-pharmaceutical-market 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-15T12:38:20+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-forest-announce-development-and-marketing-collaboration-agreement 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/dr-john-efthimiou-new-rd-global-medical-director-almirall 2026-04-15T09:13:07+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-publish-clinical-trials 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-15T11:05:34+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-commemorates-5th-anniversary-almogran-its-own-rd-medicine-treatment 2026-04-15T09:13:40+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-gw-announce-european-development-and-marketing-agreement-sativexr 2026-04-15T09:55:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-grants-commercialisation-almogran-switzerland-pharmaceutical-company 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-italy-signs-agreement-altana-pharma-ag-commercialisation-pantopan 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-only-pharmaceutical-company-be-awarded-best-european-business-prize 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-confers-2005-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-collaboration-sareum-protein-structure-determination 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-enters-long-term-compound-library-agreement-evotec 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low 2026-04-15T10:32:27+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/according-survey-el-club-de-la-farmacia-website-portal-which-over-30000 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-reaches-sales-figures-900-million-euros-2004 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-awarded-prince-felipe-prize-business-competitiveness-large-enterprises 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-announces-parkinsons-disease-research-programme-licensing-agreement 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-confers-2004-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-has-taken-strategic-decision-registering-almotriptan-japan 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-increases-sales-64-2003 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almotriptan-receives-approval-be-sold-canada 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-awarded-iso-1400196-environmental-management-certification 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-confers-2003-pharmacology-award 2026-04-15T11:06:13+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/canada-another-key-approval-almotriptan 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-presents-its-new-corporate-website 2026-04-15T11:14:53+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-15T11:15:28+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-consolidates-its-international-expansion-opening 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-confers-2002-pharmacology-award 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-invests-30-million-euros-new-research-and-development 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/comparative-study-classifies-almogran-one-best-choices-treatment-migraines 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-opens-new-laboratory-barcelona-science-park 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-establishes-its-presence-france-acquisition-pharmafarm 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-licenses-antipsychotic-agent-blonanserin-dainippon 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almotriptan-almogran-licensed-fda-marketing-united-states 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-prodesfarma-acquires-prasfarma 2026-04-15T10:00:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-inaugurates-offices-china-advance-innovation-medical-dermatology 2026-04-30T09:02:10+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/lebrikizumab-delivered-significant-skin-clearance-and-improved-disease-severity 2026-04-30T09:49:44+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almiralls-17th-skin-academy-highlights-scientific-advances-inflammatory-skin 2026-05-11T13:16:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/aad-2026-almirall-presents-new-clinical-and-real-world-evidence-across-atopic 2026-04-30T09:24:15+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-enters-collaboration-huaota-development-novel-monoclonal-antibody 2026-04-30T09:28:50+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/lebrikizumab-delivered-long-term-disease-control-four-years-patients-moderate 2026-04-30T09:37:48+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-and-barcelona-supercomputing-center-expand-their-collaboration 2026-04-30T09:47:14+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/financial-results-q1-2026 2026-05-11T16:32:05+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/2025-year-review-entering-era-sustained-growth 2026-05-12T07:40:24+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/annual-general-shareholders-meeting 2026-05-11T11:11:02+00:00 weekly 1 https://www.almirall.com/news-media/newsroom/almirall-continues-its-positive-trajectory-q1-2026-line-expectations-led-193 2026-05-11T15:52:07+00:00 weekly 1 https://www.almirall.com/dermatology/acne 2026-04-29T11:17:56+00:00 weekly 1 https://www.almirall.com/dermatology/acne/diagnosis 2026-04-29T10:10:36+00:00 weekly 1 https://www.almirall.com/dermatology/acne/signs-symptoms 2026-04-28T11:06:29+00:00 weekly 1 https://www.almirall.com/dermatology/acne/treatments 2026-04-29T11:22:01+00:00 weekly 1 https://www.almirall.com/dermatology/acne/triggering-factors 2026-04-29T10:10:21+00:00 weekly 1 https://www.almirall.com/dermatology/acne/types 2026-04-29T10:10:43+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis 2026-04-27T14:03:02+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis/diagnosis 2026-04-29T10:11:22+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis/signs-symptoms 2026-04-27T14:45:12+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis/treatments 2026-04-27T14:26:25+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis/triggering-factors 2026-04-27T14:44:22+00:00 weekly 1 https://www.almirall.com/dermatology/actinic-keratosis/types 2026-05-11T17:37:25+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata 2026-04-27T12:23:07+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata/diagnosis 2026-04-27T14:29:36+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata/signs-symptoms 2026-04-27T14:13:38+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata/treatments 2026-04-27T13:36:59+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata/triggering-factors 2026-04-27T13:54:20+00:00 weekly 1 https://www.almirall.com/dermatology/alopecia-areata/types 2026-04-27T14:33:06+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis 2026-04-28T07:30:40+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis/diagnosis 2026-04-29T08:47:57+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis/signs-symptoms 2026-04-15T14:40:36+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis/treatments 2026-05-11T17:38:34+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis/triggering-factors 2026-04-28T08:57:45+00:00 weekly 1 https://www.almirall.com/dermatology/atopic-dermatitis/types 2026-04-29T10:58:19+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa 2026-05-12T09:35:36+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa/diagnosis 2026-04-29T08:02:27+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa/signs-symptoms 2026-05-11T08:34:35+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa/treatments 2026-04-28T14:16:45+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa/triggering-factors 2026-04-28T14:38:03+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa 2026-04-28T09:22:10+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa/diagnosis 2026-04-28T11:30:21+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa/signs-symptoms 2026-04-28T11:17:11+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa/treatments 2026-04-28T10:48:20+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa/triggering-factors 2026-04-28T11:08:15+00:00 weekly 1 https://www.almirall.com/dermatology/hidradenitis-suppurativa/types 2026-04-28T11:46:34+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer 2026-04-27T14:50:25+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer/diagnosis 2026-04-28T07:13:04+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer/signs-symptoms 2026-05-11T17:31:52+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer/treatments 2026-04-27T15:18:44+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer/triggering-factors 2026-04-28T07:06:17+00:00 weekly 1 https://www.almirall.com/dermatology/keratinocyte-cancer/types 2026-04-28T07:22:38+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis 2026-04-29T09:24:17+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis/diagnosis 2026-04-29T11:19:09+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis/signs-symptoms 2026-04-29T10:51:59+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis/treatments 2026-05-08T16:35:56+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis/triggering-factors 2026-04-29T10:33:51+00:00 weekly 1 https://www.almirall.com/dermatology/onychomycosis/types 2026-04-29T11:14:19+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis 2026-04-28T10:06:45+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis/diagnosis 2026-04-28T11:01:28+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis/signs-symptoms 2026-04-28T10:49:51+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis/treatments 2026-04-28T10:16:56+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis/triggering-factors 2026-04-28T10:35:03+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/palmoplantar-pustulosis/types 2026-04-28T11:08:04+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis 2026-04-30T08:02:30+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis/diagnosis 2026-04-27T10:39:33+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis/signs-symptoms 2026-04-27T11:13:28+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis/treatments 2026-04-27T10:05:28+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis/triggering-factors 2026-04-27T10:30:16+00:00 weekly 1 https://www.almirall.com/dermatology/psoriasis/types 2026-04-27T11:35:57+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases 2026-05-12T09:31:44+00:00 weekly 1 https://www.almirall.com/dermatology/rare-skin-diseases/congenital-epidermolysis-bullosa/types 2026-04-29T08:10:02+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo/types 2026-04-29T08:57:04+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo 2026-04-29T10:12:17+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo/diagnosis 2026-04-29T08:39:18+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo/signs-symptoms 2026-04-29T08:33:19+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo/treatments 2026-04-29T08:20:41+00:00 weekly 1 https://www.almirall.com/dermatology/vitiligo/triggering-factors 2026-04-29T08:28:24+00:00 weekly 1